Open AccessGuanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder
Author(s) -
Deepa Jahagirdar,
Quenby Mahood
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.404
Subject(s) - guanfacine , autism spectrum disorder , attention deficit hyperactivity disorder , guideline , randomized controlled trial , psychology , psychiatry , placebo , adverse effect , medicine , clinical psychology , clonidine , anesthesia , autism , pharmacology , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom